Delayed-union Fractures

Bone Therapeutics SA announces final results from Phase I/IIA ALLOB delayed-union fracture study

Gosselies, Belgium, 14 September 2018, 7 am CEST – BONE THERAPEUTICS (Euronext Brussels and Paris: BOTHE), the bone cell therapy company…